Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling
- PMID: 15134780
- DOI: 10.1016/j.coi.2004.03.014
Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling
Abstract
Phosphoinositide 3-kinase (PI3K) activation is essential for lymphocyte proliferation driven by receptors for antigen, costimulatory ligands and cytokines. The lipid products of PI3K contribute to the assembly of membrane-associated signaling complexes by promoting recruitment of selected proteins from the cytoplasm. Many proteins possess domains that are able to bind selectively to PI3K products. Different 'PI3K effector' proteins are coupled to distinct biological responses, depending on cell type and on the receptor that is engaged. In B cells and T cells, Tec-family tyrosine kinases and Akt serine/threonine kinases are emerging as crucial mediators of proliferation and survival signals downstream of PI3K. Of particular interest is recent evidence that PI3K signaling controls increases in lymphocyte size and metabolic activity that accompany cell cycle progression.
Similar articles
-
Bam32/DAPP1 promotes B cell adhesion and formation of polarized conjugates with T cells.J Immunol. 2010 Jun 15;184(12):6961-9. doi: 10.4049/jimmunol.0904176. Epub 2010 May 21. J Immunol. 2010. PMID: 20495066
-
Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.Science. 2002 Aug 9;297(5583):1031-4. doi: 10.1126/science.1073560. Epub 2002 Jul 18. Science. 2002. PMID: 12130661
-
Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses.Eur J Immunol. 2004 Nov;34(11):2968-76. doi: 10.1002/eji.200425326. Eur J Immunol. 2004. PMID: 15384044
-
PI3K in lymphocyte development, differentiation and activation.Nat Rev Immunol. 2003 Apr;3(4):317-30. doi: 10.1038/nri1056. Nat Rev Immunol. 2003. PMID: 12669022 Review.
-
Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activation.Trends Immunol. 2007 Apr;28(4):161-8. doi: 10.1016/j.it.2007.02.004. Epub 2007 Mar 1. Trends Immunol. 2007. PMID: 17336157 Review.
Cited by
-
Distinct signaling pathways regulate TLR2 co-stimulatory function in human T cells.Cell Signal. 2013 Mar;25(3):639-50. doi: 10.1016/j.cellsig.2012.11.026. Epub 2012 Dec 5. Cell Signal. 2013. PMID: 23219913 Free PMC article.
-
Nonreceptor tyrosine kinases ITK and BTK negatively regulate mast cell proinflammatory responses to lipopolysaccharide.J Allergy Clin Immunol. 2016 Apr;137(4):1197-1205. doi: 10.1016/j.jaci.2015.08.056. Epub 2015 Nov 12. J Allergy Clin Immunol. 2016. PMID: 26581914 Free PMC article.
-
Challenges and opportunities of microRNAs in lymphomas.Molecules. 2014 Sep 17;19(9):14723-81. doi: 10.3390/molecules190914723. Molecules. 2014. PMID: 25232701 Free PMC article. Review.
-
Primary antibody deficiencies.Nat Rev Immunol. 2013 Jul;13(7):519-33. doi: 10.1038/nri3466. Epub 2013 Jun 14. Nat Rev Immunol. 2013. PMID: 23765059 Review.
-
Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia.J Hematol Oncol. 2015 Jul 14;8:85. doi: 10.1186/s13045-015-0165-x. J Hematol Oncol. 2015. PMID: 26170206 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
